Amneal Pharmaceuticals (AMRX) PT Raised to $5 at RBC Capital
Tweet
Share
E-mailGet Alerts AMRX Hot Sheet
Price: $0.09 +12.50%
Rating Summary:
6 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 16 | New: 67
Rating Summary:
6 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 16 | New: 67
Trade Now!
Join SI Premium – FREE
RBC Capital analyst Randall Stanicky raised the price target on Amneal Pharmaceuticals (: AMRX) to $5.00 (from $4.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Goldman Sachs Upgrades People's Insurance Co Group of China Ltd (1339:HK) (PINXY) to Buy
- Ten Entertainment Group Plc. (TEG:LN) PT Raised to GBP3.25 at Berenberg
- S4 Capital Plc. (SFOR:LN) PT Raised to GBP6.70 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
